Ionis Pharmaceuticals Inc (IONS) Stock Analysis

Ionis Pharmaceuticals Inc (IONS) is a publicly traded company in the HEALTHCARE sector. It trades at $72.97, carries a market capitalization of $12.46B. This page summarizes the public market data, fundamentals, and frequently asked questions for IONS, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Ionis Pharmaceuticals Inc currently has a Bullish sentiment score of 0.54.

About Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals, Inc. is a pioneering biopharmaceutical company based in Carlsbad, California, renowned for its innovative RNA-targeted therapies designed to address severe and complex diseases. Utilizing its proprietary antisense technology, Ionis is dedicated to fulfilling unmet medical needs across various therapeutic areas, including neurological disorders, cardiovascular diseases, and oncology. With a diverse pipeline featuring both proprietary assets and strategic collaborations, ...

GNG Research Analysis

GNG Research scores Ionis Pharmaceuticals Inc (IONS) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for IONS.

Frequently Asked Questions

Does IONS pay dividends?

Ionis Pharmaceuticals Inc (IONS) does not currently pay a regular dividend.

What is IONS's market cap?

Ionis Pharmaceuticals Inc (IONS) has a market capitalization of $12.46B with a current stock price of $72.97.